• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于纳米材料危害评估的肺类器官。

Lung Organoids for Hazard Assessment of Nanomaterials.

机构信息

Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center Munich (CPC-M), Helmholtz Center Munich, Research Center for Environmental Health, 85764 München, Germany.

German Center of Lung Research (DZL), Comprehensive Pneumology Center Munich (CPC-M), 81377 München, Germany.

出版信息

Int J Mol Sci. 2022 Dec 10;23(24):15666. doi: 10.3390/ijms232415666.

DOI:10.3390/ijms232415666
PMID:36555307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9779559/
Abstract

Lung epithelial organoids for the hazard assessment of inhaled nanomaterials offer a promising improvement to in vitro culture systems used so far. Organoids grow in three-dimensional (3D) spheres and can be derived from either induced pluripotent stem cells (iPSC) or primary lung tissue stem cells from either human or mouse. In this perspective we will highlight advantages and disadvantages of traditional culture systems frequently used for testing nanomaterials and compare them to lung epithelial organoids. We also discuss the differences between tissue and iPSC-derived organoids and give an outlook in which direction the whole field could possibly go with these versatile tools.

摘要

用于评估吸入性纳米材料危害的肺上皮类器官为迄今为止使用的体外培养系统提供了一个很有前途的改进。类器官在三维(3D)球体中生长,可以源自诱导多能干细胞(iPSC)或源自人或小鼠的原代肺组织干细胞。在本观点中,我们将重点介绍常用于测试纳米材料的传统培养系统的优缺点,并将其与肺上皮类器官进行比较。我们还讨论了组织和 iPSC 衍生类器官之间的差异,并展望了这个多功能工具可能会在哪些方向发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a105/9779559/5d401dc1fa4e/ijms-23-15666-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a105/9779559/a1736b7383f9/ijms-23-15666-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a105/9779559/5d401dc1fa4e/ijms-23-15666-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a105/9779559/a1736b7383f9/ijms-23-15666-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a105/9779559/5d401dc1fa4e/ijms-23-15666-g002.jpg

相似文献

1
Lung Organoids for Hazard Assessment of Nanomaterials.用于纳米材料危害评估的肺类器官。
Int J Mol Sci. 2022 Dec 10;23(24):15666. doi: 10.3390/ijms232415666.
2
Generation of 3D Whole Lung Organoids from Induced Pluripotent Stem Cells for Modeling Lung Developmental Biology and Disease.从诱导多能干细胞生成 3D 全肺类器官用于肺发育生物学和疾病建模。
J Vis Exp. 2021 Apr 12(170). doi: 10.3791/62456.
3
Human pluripotent stem cell-derived lung organoids: Potential applications in development and disease modeling.人多能干细胞衍生的肺类器官:在发育和疾病建模中的潜在应用。
Wiley Interdiscip Rev Dev Biol. 2021 Nov;10(6):e399. doi: 10.1002/wdev.399. Epub 2020 Nov 3.
4
Microstructured Hydrogels to Guide Self-Assembly and Function of Lung Alveolospheres.微结构化水凝胶引导肺类器官的自组装和功能。
Adv Mater. 2022 Jul;34(28):e2202992. doi: 10.1002/adma.202202992. Epub 2022 Jun 7.
5
iPSC-Derived Airway Epithelial Cells: Progress, Promise, and Challenges.诱导多能干细胞衍生的气道上皮细胞:进展、前景与挑战。
Stem Cells. 2023 Jan 30;41(1):1-10. doi: 10.1093/stmcls/sxac074.
6
Generation of iPSC-Derived Brain Organoids for Drug Testing and Toxicological Evaluation.诱导多能干细胞衍生脑类器官用于药物测试和毒理学评估。
Methods Mol Biol. 2022;2474:93-105. doi: 10.1007/978-1-0716-2213-1_10.
7
Lung Organoids-The Ultimate Tool to Dissect Pulmonary Diseases?肺类器官——剖析肺部疾病的终极工具?
Front Cell Dev Biol. 2022 Jul 13;10:899368. doi: 10.3389/fcell.2022.899368. eCollection 2022.
8
In vitro generation of human pluripotent stem cell derived lung organoids.人多能干细胞来源的肺类器官的体外生成。
Elife. 2015 Mar 24;4:e05098. doi: 10.7554/eLife.05098.
9
Generation of Complete Multi-Cell Type Lung Organoids From Human Embryonic and Patient-Specific Induced Pluripotent Stem Cells for Infectious Disease Modeling and Therapeutics Validation.从人类胚胎干细胞和患者特异性诱导多能干细胞生成完整的多细胞类型肺类器官用于传染病建模和治疗验证。
Curr Protoc Stem Cell Biol. 2020 Sep;54(1):e118. doi: 10.1002/cpsc.118.
10
Reversal of Surfactant Protein B Deficiency in Patient Specific Human Induced Pluripotent Stem Cell Derived Lung Organoids by Gene Therapy.基因治疗纠正患者特异性人诱导多能干细胞衍生肺类器官中表面活性蛋白 B 缺乏。
Sci Rep. 2019 Sep 17;9(1):13450. doi: 10.1038/s41598-019-49696-8.

引用本文的文献

1
The Risks Associated with Inhalation Exposure to Cosmetics and Potential for Assessment Using Lung Organoids.吸入接触化妆品相关风险及使用肺类器官进行评估的可能性。
Bioengineering (Basel). 2025 Jun 13;12(6):652. doi: 10.3390/bioengineering12060652.
2
Models to evaluate the pulmonary toxicity of desert dust and what we have learned from them so far: a mini-review.评估沙漠尘土肺毒性的模型以及我们目前从中获得的认识:一篇小型综述。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 29. doi: 10.1007/s00210-025-03891-9.
3
Twenty years of nanotoxicology: how AI could make the difference.

本文引用的文献

1
Real-Time Measurement of Cell Mechanics as a Clinically Relevant Readout of an In Vitro Lung Fibrosis Model Established on a Bioinspired Basement Membrane.实时测量细胞力学,作为基于仿生基底膜的体外肺纤维化模型的一种临床相关读出指标。
Adv Mater. 2022 Oct;34(41):e2205083. doi: 10.1002/adma.202205083. Epub 2022 Sep 11.
2
Diesel exhaust particles distort lung epithelial progenitors and their fibroblast niche.柴油机废气颗粒会使肺上皮祖细胞及其成纤维细胞龛发生变形。
Environ Pollut. 2022 Jul 15;305:119292. doi: 10.1016/j.envpol.2022.119292. Epub 2022 Apr 18.
3
Human organoid models to study SARS-CoV-2 infection.
纳米毒理学二十年:人工智能如何发挥作用。
Front Toxicol. 2024 Sep 18;6:1470439. doi: 10.3389/ftox.2024.1470439. eCollection 2024.
4
Cytokine signaling converging on in ILD fibroblasts provokes aberrant epithelial differentiation signatures.细胞因子信号在特发性肺纤维化成纤维细胞中汇聚,引发异常的上皮分化特征。
Front Immunol. 2023 May 17;14:1128239. doi: 10.3389/fimmu.2023.1128239. eCollection 2023.
人类类器官模型用于研究 SARS-CoV-2 感染。
Nat Methods. 2022 Apr;19(4):418-428. doi: 10.1038/s41592-022-01453-y. Epub 2022 Apr 8.
4
Impaired AT2 to AT1 cell transition in PM2.5-induced mouse model of chronic obstructive pulmonary disease.PM2.5 诱导的慢性阻塞性肺疾病小鼠模型中 AT2 向 AT1 细胞转化受损。
Respir Res. 2022 Mar 25;23(1):70. doi: 10.1186/s12931-022-01996-w.
5
Application of evidence-based methods to construct mechanism-driven chemical assessment frameworks.应用循证方法构建基于机制的化学评估框架。
ALTEX. 2022;39(3):499–518. doi: 10.14573/altex.2202141. Epub 2022 Mar 1.
6
An adverse outcome pathway for lung surfactant function inhibition leading to decreased lung function.一条导致肺功能下降的肺表面活性物质功能抑制的不良结局途径。
Curr Res Toxicol. 2021 May 27;2:225-236. doi: 10.1016/j.crtox.2021.05.005. eCollection 2021.
7
Development of Human Lung Induction Models for Air Pollutants' Toxicity Assessment.用于评估空气污染物毒性的人肺诱导模型的开发。
Environ Sci Technol. 2021 Feb 16;55(4):2440-2451. doi: 10.1021/acs.est.0c05700. Epub 2021 Feb 4.
8
Air-Liquid Interface Exposure of Lung Epithelial Cells to Low Doses of Nanoparticles to Assess Pulmonary Adverse Effects.肺上皮细胞在气液界面暴露于低剂量纳米颗粒以评估肺部不良反应
Nanomaterials (Basel). 2020 Dec 29;11(1):65. doi: 10.3390/nano11010065.
9
Progenitor identification and SARS-CoV-2 infection in human distal lung organoids.人远端肺类器官中的祖细胞鉴定和 SARS-CoV-2 感染。
Nature. 2020 Dec;588(7839):670-675. doi: 10.1038/s41586-020-3014-1. Epub 2020 Nov 25.
10
A molecular cell atlas of the human lung from single-cell RNA sequencing.人类肺部单细胞 RNA 测序的分子细胞图谱。
Nature. 2020 Nov;587(7835):619-625. doi: 10.1038/s41586-020-2922-4. Epub 2020 Nov 18.